Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms (SPARE)

Next Previous
Search
Trial Profile

Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms (SPARE)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Isoflavone/soybean protein (Primary)
  • Indications Menopause; Metabolic bone diseases; Osteoporosis
  • Focus Therapeutic Use
  • Acronyms SPARE

    • Most Recent Events

    • 06 Dec 2016 Biomarkers information updated
    • 13 Sep 2011 New trial record
    • 08 Aug 2011 Results published in the Archives of Internal Medicine indicate that the trial was conducted from 1 July 2004 to the 31 March 2009.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top